Free Trial

Stock Traders Purchase Large Volume of Call Options on Siga Technologies (NASDAQ:SIGA)

Siga Technologies logo with Medical background

Key Points

  • On a single day, traders bought around 1,200 call options for Siga Technologies, marking a significant increase of 1,438% compared to average trading volume.
  • Siga Technologies' shares opened at $8.42, with a market cap of approximately $602.96 million and a notable net margin of 45.73%.
  • Analysts have mixed ratings on Siga Technologies, with Weiss Ratings maintaining a "hold" rating, while Wall Street Zen upgraded it to a "strong-buy," reflecting differing perspectives on the stock's potential.
  • MarketBeat previews top five stocks to own in November.

Siga Technologies Inc. (NASDAQ:SIGA - Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Traders bought 1,200 call options on the stock. This is an increase of 1,438% compared to the typical volume of 78 call options.

Siga Technologies Price Performance

Shares of NASDAQ SIGA opened at $8.42 on Thursday. Siga Technologies has a 1 year low of $4.95 and a 1 year high of $9.62. The stock has a market cap of $602.96 million, a P/E ratio of 7.45 and a beta of 0.96. The firm has a 50-day moving average of $8.73 and a 200 day moving average of $7.09.

Siga Technologies (NASDAQ:SIGA - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.49 earnings per share (EPS) for the quarter. Siga Technologies had a net margin of 45.73% and a return on equity of 40.52%. The company had revenue of $81.12 million during the quarter. Research analysts expect that Siga Technologies will post 1.04 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the business. Hotchkis & Wiley Capital Management LLC lifted its position in Siga Technologies by 52.9% during the 1st quarter. Hotchkis & Wiley Capital Management LLC now owns 3,158,320 shares of the company's stock valued at $17,308,000 after acquiring an additional 1,093,080 shares during the period. American Century Companies Inc. lifted its position in Siga Technologies by 2.5% during the 2nd quarter. American Century Companies Inc. now owns 1,405,174 shares of the company's stock valued at $9,162,000 after acquiring an additional 34,514 shares during the period. New York State Common Retirement Fund raised its holdings in Siga Technologies by 0.6% in the second quarter. New York State Common Retirement Fund now owns 593,050 shares of the company's stock worth $3,867,000 after buying an additional 3,430 shares during the last quarter. Uniplan Investment Counsel Inc. raised its holdings in Siga Technologies by 0.7% in the first quarter. Uniplan Investment Counsel Inc. now owns 504,561 shares of the company's stock worth $2,765,000 after buying an additional 3,572 shares during the last quarter. Finally, Foundry Partners LLC raised its holdings in Siga Technologies by 1.4% in the first quarter. Foundry Partners LLC now owns 447,783 shares of the company's stock worth $2,454,000 after buying an additional 6,054 shares during the last quarter. 55.40% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently commented on SIGA shares. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Siga Technologies in a research report on Wednesday, October 8th. Wall Street Zen raised shares of Siga Technologies from a "hold" rating to a "strong-buy" rating in a research report on Saturday, August 9th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the company has a consensus rating of "Hold".

Get Our Latest Analysis on Siga Technologies

About Siga Technologies

(Get Free Report)

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Siga Technologies Right Now?

Before you consider Siga Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Siga Technologies wasn't on the list.

While Siga Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.